SAN FRANCISCO, Jan. 19, 2011 /PRNewswire/ -- Medizone International, Inc. (OTC Bulletin Board: MZEI) (OTCQB: MZEI) announced today that it has entered into a final product development and production agreement for the manufacture of its AsepticSure™ Advanced Oxidative Sterilization Processes, with ADA Innovations of Toronto, Canada.
Edwin Marshall, CEO of Medizone, commented, "Purely from a corporate perspective, ADA is a 'new kid on the block' - but what the development team behind it brings to the table for the future of AsepticSure™, exceeds all of our expectations."
ADA founders and directors, Mark Costa B.A. Sc Mechanical Engineering and Hao (Hawk) Chen M.S. Biomedical Engineering, bring more than 20 years of high-level experience to this project from the top echelons of industry – both in the engineering and medical device sectors.
Datascope Patient Monitoring (now Mindray North America), Husky, along with global medical device manufacturing giant, Mindray International, are just three of the big-name corporations on Mark and Hawk's respective resumes. Others of significance include; Vasogen and Hologic.
Marshall commented, "After short-listing five potential manufacturing partners – each with impressive backgrounds in medical device development – ADA stood out as a logical choice for us, for two reasons: They were the only group who boasted a depth of knowledge in Ozone based technologies AND experience in medical device design, building and product launch."
Dr Michael Shannon, Medizone's Director of Medical affairs, added, "The dual qualifications that ADA brings to this collaborative venture are not only unique in the medical device industry, but are also essential to the achieve
|SOURCE Medizone International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved